Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 12, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Pilot Study on MAGE-C2 as a Potential Biomarker for Triple-Negative Breast Cancer.

Qian Zhao¹, Wen-Ting Xu¹, Tuluhong Shalieer¹

¹Department of Breast Surgery, The Affiliated Tumor Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830011, China.

Disease Markers

|November 16, 2016

Summary

High expression of melanoma antigen gene c2 (MAGE-C2) in triple-negative breast cancer (TNBC) correlates with poorer prognosis. MAGE-C2 may be an independent prognostic factor for TNBC patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An ultra-sensitive and colorimetric sensor for copper and iron based on glutathione-functionalized gold nanoclusters.

Analytica chimica acta·2016

Same author

Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B.

Medicine·2016

Same author

Congenital hepatic cyst with intracystic hemorrhage: Two rare cases reports in the Chinese Han population.

Medicine·2016

Same author

Quantitative multimodal multiparametric imaging in Alzheimer's disease.

Brain informatics·2016

Same author

Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.

Biochimica et biophysica acta·2016

Same author

Corrigendum to "State of the art of biological processes for coal gasification wastewater treatment" [Biotechnol. Adv. 34/5 (2016) 1064-1072].

Biotechnology advances·2016

Area of Science:

Oncology
Molecular Biology
Cancer Research

Background:

Triple-negative breast cancer (TNBC) is an aggressive subtype with limited targeted therapies.
Melanoma antigen gene c2 (MAGE-C2) is a potential tumor antigen implicated in various cancers.

Purpose of the Study:

To investigate the expression status of MAGE-C2 in TNBC tissues.
To analyze the correlation between MAGE-C2 expression and clinicopathological features.
To evaluate the prognostic value of MAGE-C2 in TNBC patients.

Main Methods:

Immunohistochemistry, RT-PCR, and western blotting were used to detect MAGE-C2 expression in TNBC and adjacent tissues.
Chi-squared tests analyzed the association with clinicopathological parameters.
Kaplan-Meier and Cox proportional hazards models assessed survival outcomes.

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Related Experiment Videos

Last Updated: Mar 12, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Main Results:

MAGE-C2 was highly expressed in 38.18% of TNBC tissues compared to 9.09% in adjacent tissues.
High MAGE-C2 expression correlated significantly with lymph node status, TNM stage, and lymphovascular invasion (P < 0.001).
Patients with high MAGE-C2 expression exhibited significantly shorter survival times.

Conclusions:

MAGE-C2 is frequently overexpressed in TNBC.
MAGE-C2 expression is associated with aggressive clinicopathological features and poor prognosis in TNBC.
MAGE-C2 may serve as an independent prognostic biomarker for TNBC.